We are live on ! Find out more
MRM icon

MEDIROM Healthcare Technologies

6 hedge funds and large institutions have $103K invested in MEDIROM Healthcare Technologies in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

100% more funds holding

Funds holding: 3 → 6 (+3)

1.35% less ownership

Funds ownership: 2.28% → 0.92% (-1.4%)

83% less capital inflows, than outflows

Capital inflows: $22.4K | Capital outflows: $130K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MRM Hedge Fund Activity: Q2 2025 in Review

6 of the 7,627 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q2 2025, worth a combined $103K — up 56% from $66K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new MRM positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Mariner, opening a new position worth an estimated $21K. The largest seller was UBS Group, cutting an estimated $71.9K.

  • 6 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q2 2025, up from 3 in Q1 2025.
  • Funds reported $103K of MEDIROM Healthcare Technologies stock for Q2 2025, up 56% quarter-over-quarter.
  • 4 funds opened new MEDIROM Healthcare Technologies positions in Q2 2025 and 1 closed out, a net change of +3 holders.
  • The largest MEDIROM Healthcare Technologies buyer in Q2 2025 was Mariner, an estimated $21K added.
  • The largest MEDIROM Healthcare Technologies seller in Q2 2025 was UBS Group, an estimated $71.9K sold.

Based on aggregated 13F filings for Q2 2025.